Statement
27 Aug 2025
AMATA statement at 75th WHO AFRO: Progress report on the regional strategy on regulation of medical products in African region
On 27 August 2025, the African Medicines Agency Treaty Alliance submitted a statement on agenda item 16.8: Progress report on the regional strategy on regulation of medical products in African region, 2016-2025 at the 75th Session of the WHO Regional Committee for Africa. The African Medicines Agency Treaty Alliance (AMATA) commends the progress made under...
Read more
Infographic
23 Jul 2025
Streamlining samples management to strengthen health outcomes in Africa
Ensuring the quality, safety, and efficacy of pharmaceutical products is a cornerstone of public health. To meet these high standards, innovative multinational pharmaceutical companies perform rigorous batch release testing for every product, following internationally recognized protocols and approved specifications. However, countries may require additional in-country testing by their National Regulatory Authorities (NRAs) or National Control...
Read more
Statement
5 Jun 2025
AMATA statement on the appointment of Dr Delese Mimi Darko as Director General of the African Medicines Agency
The founding members of the African Medicine Agency Treaty Alliance: Amref Health Africa, the Association of African Universities North Africa Regional Office, the International Alliance of Patients’ Organizations, the International Federation of Pharmaceutical Manufacturers and Associations, the International Pharmaceutical Students’ Federation, NCD Alliance Kenya, PATH, Speak up Africa and the University of the Witwatersrand, welcome...
Read more